Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) CEO Sells $30,244.20 in Stock

Bicara Therapeutics Inc. (NASDAQ: BCAX - Get Free Report) CEO Claire Mazumdar sold 1,596 shares of the stock in a transaction on Friday, March 20th. The shares were sold at an average price of $18.95, for a total value of $30,244.20. Following the transaction, the chief executive officer directly owned 339,392 shares of the company's stock,